Adaptive confirmation of treatable arrhythmia in implantable cardiac stimulus devices

• US 9,149,637 B2
• Filed: 06/29/2010
• Issued: 10/06/2015
• Est. Priority Date: 06/29/2009
• Status: Active Grant

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Warren, Jay A., Sanghera, Rick, Allavatam, Venugopal
• Primary Examiner(s): Lee, Erica
• Application Number:
  US12/826,241
• Publication Number:
  US 20100331904A1
• Time in Patent Office: 1,925 Days
• Field of Search: 607/4, 607/5, 607/9, 607/14, 607/17
• US Class Current: 1/1
• CPC Class Codes: A61B 5/363 Detecting tachycardia or bradycardia
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/3943 for threshold determination
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3987 characterised by the timing or triggering of the shock

Abstract

Methods and devices for adjusting therapy delivery decisions in an implantable cardiac stimulus device by observing cardiac activity following an initial identification of a treatable condition. In some examples, cardiac activity that appears benign is quantified and a therapy confirmation threshold is adjusted according to how much apparently benign cardiac activity is seen after an initial identification of a treatable condition. In other examples, a new threshold is applied following the initial identification of treatable condition, removing historical data preceding the initial identification from subsequent therapy delivery decisions.

Claims

1. A method of operation in an implantable cardiac stimulus device (ICSD) comprising a housing that contains a battery power source and operational circuitry that operates by analyzing cardiac signals from implanted electrode(s) in order to determine whether a treatable arrhythmia is detected, the method comprising:

the ICSD making an initial determination that a treatable cardiac arrhythmia is occurring;

the ICSD preparing to deliver therapy in response to the initial determination and, while preparing to deliver therapy, observing whether indications of benign cardiac rhythm are detected;

when the ICSD is prepared to deliver therapy, applying Confirmation criteria to confirm the treatable cardiac arrhythmia is ongoing, the Confirmation criteria comprising a Therapy threshold and the Confirmation criteria is applied by;

counting intervals between events detected from sensed cardiac signals that are shorter than a short interval threshold to generate a Short Interval Count (SIC); and

comparing SIC to the Therapy threshold; and

if the Confirmation criteria are met, delivering therapy from the ICSD;

wherein the method comprises the ICSD changing the Confirmation criteria in response to identification of one or more of the indications of benign cardiac rhythm while the ICSD is preparing to deliver therapy by increasing the Therapy threshold to require a larger SIC value;

further wherein the Confirmation criteria are actively updated and re-applied until either therapy is delivered or the ICSD determines that therapy is not needed;

further wherein;

the ICSD uses an event detection method in which events are detected from sensed cardiac signals, and intervals between the detected events are used to estimate cardiac rate for use in the initial determination that a treatable cardiac arrhythmia is occurring.

2. The method of claim 1 wherein preparing to deliver therapy comprises charging an output capacitor to a therapy level for delivery of therapy.

3. The method of claim 1 wherein preparing to deliver therapy comprises waiting for a timer to expire after the initial determination and before delivering therapy.

4. The method of claim 1 wherein preparing to deliver therapy comprises waiting for a predetermined number of cardiac events to be detected after the initial determination and before delivering therapy.

5. The method of claim 1 wherein an indication of benign cardiac rhythm is identified when a cardiac rate slower than a slow-rate threshold is detected.

6. The method of claim 1 comprising further modifying the Confirmation criteria if, after modification of the Confirmation criteria in response to indications of benign cardiac rhythm, a treatable cardiac arrhythmia is detected.

7. The method of claim 1 wherein, if indications of a benign cardiac rhythm are identified and the Therapy threshold is increased, if indications of treatable cardiac arrhythmia follow, the method further comprises modifying the Confirmation criteria by reducing the Therapy threshold.

8. The method of claim 1 wherein:

the ICSD uses the event detection method and makes the initial determination by determining whether detected events have morphologies indicating that a treatable cardiac arrhythmia is occurring; and

the indications of benign rhythm comprise morphology data indicating that the treatable cardiac arrhythmia is not ongoing; and

the morphology of detected events is analyzed by the ICSD using one or more of;

detected event width;

detected event amplitude;

detected event correlation to template or lack thereof; and

event-to-event variability.

9. An implantable cardiac stimulus device (ICSD) comprising a housing that contains a battery power source and operational circuitry that operates by analyzing cardiac signal data from implanted electrodes in order to determine whether a treatable arrhythmia is detected, ICSD configured to perform a method of verifying therapy delivery comprising:

the ICSD making an initial determination that a treatable cardiac arrhythmia is occurring;

after making an initial determination that a treatable cardiac arrhythmia is occurring, the ICSD preparing to deliver therapy;

while the ICSD is preparing to deliver therapy, observing whether indications of benign cardiac rhythm are detected;

when the ICSD is prepared to deliver therapy, the ICSD applying Confirmation criteria to ensure the treatable cardiac arrhythmia is ongoing, the Confirmation criteria comprising a Therapy threshold and the Confirmation criteria is applied by;

counting intervals between events detected from sensed cardiac signals that are shorter than a short interval threshold to generate a Short Interval Count (SIC); and

comparing SIC to the Therapy threshold; and

if the Confirmation criteria are met, the ICSD delivering therapy;

wherein the method comprises the ICSD changing the Confirmation criteria in response to identification of one or more indications of a benign cardiac rhythm while the ICSD is preparing to deliver therapy by increasing the Therapy threshold to require a larger SIC value;

further wherein the Confirmation criteria are actively updated and re-applied until either therapy is delivered or the ICSD determines that therapy is not needed;

further wherein;

the operational circuitry is configured to use an event detection method in which cardiac events are detected from the sensed cardiac signals, and intervals between the detected cardiac events are used by the controller to estimate cardiac rate for use in the initial determination that a treatable cardiac arrhythmia is occurring.

10. The ICSD of claim 9 wherein the operational circuitry includes:

an output capacitor and a charger coupled to the output capacitor such that the output capacitor can be charged by the charger to temporarily store therapeutic energy prior to delivering therapy;

input circuitry for receiving sensed cardiac signals from the implanted electrodes and amplifying and filtering the input signals;

a controller coupled to the input circuitry, output capacitor, output circuitry, and charger and controlling the functions thereof, the controller configured to determine whether a treatable arrhythmia is detected and to perform the method of verifying therapy delivery; and

a battery providing power to the operational circuitry.

11. The ICSD of claim 10 wherein the ICSD prepares to deliver therapy by charging the output capacitor to a therapy level for delivery of therapy.

12. The ICSD of claim 9 wherein the ICSD prepares to deliver therapy by waiting for a timer to expire after the initial determination and before delivering therapy.

13. The ICSD of claim 9 wherein the ICSD prepares to deliver therapy by waiting for a predetermined number of cardiac events to be detected after the initial determination and before delivering therapy.

14. The ICSD of claim 9 wherein, in the method of verifying therapy delivery, an indication of benign cardiac rhythm is identified when a cardiac rate below a slow-rate threshold is detected.

15. The ICSD of claim 9 wherein, in the method of verifying therapy delivery, if indications of a benign cardiac rhythm are identified and the Therapy threshold is increased, if indications of treatable cardiac arrhythmia follow, the method further comprises modifying the Confirmation criteria by reducing the Therapy threshold.

16. The ICSD of claim 9 wherein the housing comprises either:

a single unit protecting the battery power source and operational circuitry, the operational circuitry including a processor and associated logic and memory to allow carrying out of the steps of the method;

or

a plurality of units containing and protecting the battery and operational circuitry in a number of separate elements.

17. The ICSD of claim 9 wherein:

the ICSD uses an event detection method and makes the initial determination by determining whether detected events have morphologies indicating that a treatable cardiac arrhythmia is occurring; and

the indications of benign rhythm comprise morphology data indicating that the treatable cardiac arrhythmia is not ongoing; and

the morphology of detected events is analyzed by the ICSD using one or more of;

detected event width;

detected event amplitude;

detected event correlation to template or lack thereof;

and event-to-event variability.

18. An implantable cardiac stimulus device (ICSD) that operates by analyzing cardiac signal data from implanted electrodes in order to determine whether a treatable arrhythmia needs therapy by:

detecting cardiac events using the implanted electrodes;

establishing an X/Y Counter with X indicating a number of Treatable detected cardiac arrhythmia events out of a set of Y detected cardiac events; and

determining whether the X/Y Counter meets at least a Therapy threshold condition and, if so, the ICSD determining that a treatable arrhythmia needs therapy and beginning to prepare for therapy delivery, wherein the Therapy threshold condition calls for X/Y to yield 18 out of 24 detected cardiac events as Treatable detected cardiac arrhythmia events;

wherein the ICSD is also configured to perform a method of verifying therapy delivery when the ICSD begins to prepare for therapy delivery, the method of verifying therapy delivery comprising;

resetting the X/Y counter such that X is zero;

detecting cardiac events and refilling the X/Y counter while the ICSD prepares to deliver therapy;

determining that the ICSD is ready to deliver therapy;

once the ICSD is ready to deliver therapy, if the X/Y counter exceeds a Confirmation threshold condition, delivering therapy;

or, if not, waiting for additional detected cardiac events, in which the Confirmation threshold condition calls for X/Y to yield 12/16 detected cardiac events as Treatable detected cardiac arrhythmia events.

19. The ICSD of claim 18 wherein the ICSD prepares to deliver therapy by charging an output capacitor to a therapy level for delivery of therapy.

20. The ICSD of claim 18 wherein the ICSD prepares to deliver therapy by waiting for a timer to expire before delivering therapy.

21. The ICSD of claim 18 wherein the ICSD prepares to deliver therapy by waiting for a predetermined number of cardiac events to be detected before delivering therapy.

22. The ICSD of claim 18 wherein the ICSD is configured to identify Treatable cardiac arrhythmia events using an estimated cardiac rate.

23. The ICSD of claim 18 wherein the ICSD is configured to identify Treatable cardiac arrhythmia events using morphology analysis including one or more of:

detected cardiac event width;

detected cardiac event amplitude;

detected cardiac event correlation to template or lack thereof;

and variability from one detected cardiac event to another detected cardiac event.

24. The ICSD of claim 18 wherein the ICSD comprises a housing and operational circuitry in the housing including:

an output capacitor and a charger, the output capacitor configured to receive and temporarily store therapeutic energy from the charger for purposes of preparing to deliver therapy;

input circuitry for receiving input signals from the implanted electrodes and amplifying and filtering the input signals;

a controller coupled to the input circuitry, output capacitor, output circuitry, and charger and controlling the functions thereof, the controller configured to determine whether a treatable cardiac arrhythmia is detected and to perform the method of verifying therapy delivery; and

a battery providing power to the operational circuitry.

25. An implantable cardiac stimulus device (ICSD) comprising a canister housing operational circuitry for the ICSD, the operational circuitry including a defibrillation capacitor for storing defibrillation energy and a charging circuit for charging the defibrillation capacitor to a therapeutic energy level, the canister including at least one electrode thereon, and a lead electrode coupled to the canister and carrying electrodes coupled to the operational circuitry, the operational circuitry being configured to perform a method comprising:

capturing cardiac signals from the electrodes;

determining that a tachyarrhythmia or fibrillation is occurring and needs therapy;

activating the charging circuit to charge the defibrillation capacitor;

detecting cardiac events after the charging circuit is activated and keeping a long interval count by;

a) establishing an initial value for the long interval count when the charging circuit is activated, and

b) incrementing the long interval count when a long interval between two detected cardiac events occurs, or

c) decrementing the long interval count when a short interval between two detected cardiac events occurs, the decrementing step being limited by the initial value;

determining whether charging is complete, and,

if so, determining whether a Confirmation condition is met, the Confirmation condition requiring a series of detected cardiac events to indicate therapy delivery, wherein the series of detected cardiac events has a length defined by the long interval count, and

if so, delivering therapy to the patient.